Solventum (SOLV)
Makes wound-care, surgical, and dental products alongside healthcare workflow software.
$88.75
After hours−0.03 (−0.04%)
At close$88.79(−0.06%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
$1.37
Revenue estimate
$1.94B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$1.41$1.34$1.69$1.50$1.57$1.48$2.55Pending
Estimate$1.31$1.21$1.45$1.43$1.50$1.35$1.90$1.37
Surprise+7.6%+10.7%+16.6%+4.9%+4.7%+9.6%+34.2%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$2.07B$2.07B$2.16B$2.10B$2.00B$2.01B$2.21BPending
Estimate$2.05B$2.02B$2.12B$2.06B$1.96B$1.97B$2.15B$1.94B
Surprise+1.1%+2.7%+2.0%+2.0%+1.8%+2.0%+2.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2030 | $2.73 | — | — |
| Sep 2030 | $2.51 | — | — |
| Jun 2030 | $3.39 | — | — |
| Mar 2030 | $2.59 | — | — |
| Dec 2029 | $2.59 | — | — |
| Sep 2029 | $2.41 | — | — |
| Jun 2029 | $2.35 | — | — |
| Mar 2029 | $1.91 | — | — |
| Dec 2028 | $2.08 | — | — |
| Sep 2028 | $1.97 | — | — |
| Jun 2028 | $2.19 | — | — |
| Mar 2028 | $1.77 | — | — |
| Dec 2027 | $1.90 | — | — |
| Sep 2027 | $1.74 | — | — |
| Jun 2027 | $1.98 | — | — |
| Mar 2027 | $1.63 | — | — |
| Dec 2026 | $1.79 | — | — |
| Nov 2026 | $1.37 | — | — |
| Aug 2026 | $1.90 | $2.55 | +34.2% |
| May 2026 | $1.35 | $1.48 | +9.6% |
| Feb 2026 | $1.50 | $1.57 | +4.7% |
| Nov 2025 | $1.43 | $1.50 | +4.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2030 | $2.73 | — | — | $2.42B | — | — | — |
| Sep 2030 | $2.51 | — | — | $2.26B | — | — | — |
| Jun 2030 | $3.39 | — | — | $2.60B | — | — | — |
| Mar 2030 | $2.59 | — | — | $2.34B | — | — | — |
| Dec 2029 | $2.59 | — | — | $2.33B | — | — | — |
| Sep 2029 | $2.41 | — | — | $2.18B | — | — | — |
| Jun 2029 | $2.35 | — | — | $2.49B | — | — | — |
| Mar 2029 | $1.91 | — | — | $2.25B | — | — | — |
| Dec 2028 | $2.08 | — | — | $2.24B | — | — | — |
| Sep 2028 | $1.97 | — | — | $2.12B | — | — | — |
| Jun 2028 | $2.19 | — | — | $2.36B | — | — | — |
| Mar 2028 | $1.77 | — | — | $2.17B | — | — | — |
| Dec 2027 | $1.90 | — | — | $2.14B | — | — | — |
| Sep 2027 | $1.74 | — | — | $2.02B | — | — | — |
| Jun 2027 | $1.98 | — | — | $2.27B | — | — | — |
| Mar 2027 | $1.63 | — | — | $2.08B | — | — | — |
| Dec 2026 | $1.79 | — | — | $2.09B | — | — | — |
| Nov 5, 2026 | $1.37 | — | — | $1.94B | — | — | — |
| Aug 5, 2026 | $1.90 | $2.55 | +34.2% | $2.15B | $2.21B | +2.6% | −5.2% |
| May 5, 2026 | $1.35 | $1.48 | +9.6% | $1.97B | $2.01B | +2.0% | +2.8% |
| Feb 26, 2026 | $1.50 | $1.57 | +4.7% | $1.96B | $2.00B | +1.8% | −3.6% |
| Nov 6, 2025 | $1.43 | $1.50 | +4.9% | $2.06B | $2.10B | +2.0% | +7.9% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 |
